SCHEMBL10150609

SCHEMBL10150609

C=CC(=O)OCCCC(C)C(C)CCCC

nearest known ligand 0.70

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 9/20 0.70
HPGD P15428 1/20 0.70
ALDH1A1 P00352 5/20 0.55
CYP3A4 P08684 2/20 0.55
ATM Q13315 1/20 0.48
TP53 P04637 3/20 0.46
HIF1A Q16665 3/20 0.46
HSD17B10 Q99714 1/20 0.46
HCAR2 Q8TDS4 3/20 0.43
THRB P10828 2/20 0.42
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20448887 0.88 TSHR (0.68) TSHRHPGDALDH1A1CYP3A4ATM
SCHEMBL11528743 0.86 TSHR (0.66) TSHRHPGDALDH1A1CYP3A4ATM
SCHEMBL12608719 0.86 TSHR (0.56) TSHRHPGDALDH1A1CYP3A4ATM
SCHEMBL23522260 0.86 TSHR (0.59) TSHRHPGDALDH1A1CYP3A4ATM
SCHEMBL23494209 0.86 TSHR (0.59) TSHRHPGDALDH1A1CYP3A4ATM
Isobutane SCHEMBL28280147 0.85 TSHR (0.88) TSHRHPGDALDH1A1CYP3A4ATM
SCHEMBL2819269 0.85 TSHR (0.73) TSHRHPGDALDH1A1CYP3A4ATM
SCHEMBL31742399 0.85 TSHR (0.68) TSHRHPGDALDH1A1CYP3A4ATM
SCHEMBL28927500 0.85 TSHR (0.68) TSHRHPGDALDH1A1CYP3A4ATM
SCHEMBL31742400 0.85 TSHR (0.68) TSHRHPGDALDH1A1CYP3A4ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329377-B2 Imide compound and chemically amplified resist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-12-11 US disclosed
US-8173350-B2 Oxime compound and resist composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-05-08 US disclosed
US-20100028807-A1 Imide Compound and Chemically Amplified Resist Composition Containing The Same SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2010-02-04 US disclosed
US-20100021847-A1 Oxime Compound and Resist Composition Containing the Same SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100028807-A1 Imide Compound and Chemically Amplified Resist Composition Containing The Same IGF1R, CCNA1, MYC TSHR 2519/4885HPGD 4030/4885ALDH1A1 386/4885
US-20100021847-A1 Oxime Compound and Resist Composition Containing the Same CYC1, UQCRB, CBR1 TSHR 841/4885HPGD 1910/4885ALDH1A1 1280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.